Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), BATM Advanced Communications's Beta is 1.2668.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications Beta vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's Beta distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
BATM Advanced Communications (CHIX:BVCL) has a Beta of 1.2668 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BATM Advanced Communications and its competitors.
Is BATM Advanced Communications' Beta too high?
BATM Advanced Communications' current Beta is 1.2668. Overall, BATM Advanced Communications has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' Beta compare to ISRG and BDX?
BATM Advanced Communications' Beta of 1.2668 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for BATM Advanced Communications and its competitors. BATM Advanced Communications's current Beta is 1.2668. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (CHIX:BVCL) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.17, compared to a current price of £0.15 — trading 10% below its estimated fair value. The current Beta is 1.2668. BATM Advanced Communications' overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For BATM Advanced Communications (CHIX:BVCL), the current Beta is 1.2668 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (CHIX:BVCL) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.15 is trading 10% below its estimated GF Value™ of £0.17.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for CHIX:BVCL:
Beta: 1.2668
GF Value™: £0.17 vs. price of £0.15 (10% below fair value)
No single metric tells the full story. See the CHIX:BVCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
40GF Score
Get the complete analysis for CHIX:BVCL
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BVCL has been successfully added to your 
